Revolutionary therapies against colon cancer: Hope from immune medicine!

Revolutionary therapies against colon cancer: Hope from immune medicine!

Wien, Österreich - The intestinal cancer month of March has once again focused on the importance of precaution and innovative therapy options. According to press.gv.at , modern forms of therapy such as immune and targeted therapies in the Vienna Health Association New standards in cancer medicine. These procedures have the potential to significantly improve the chances of survival of patients with colon cancer.

immunotherapy shows particularly promising success in the treatment of colon cancer. This form of therapy is suitable for about 15 % of patients with specific genetic characteristics. This includes around 10 to 15 % of the non -metastatic intestinal cancer patients and 4 to 5 % of patients with metastases who can benefit from immunotherapy. Treatment usually takes place every three weeks over a period of six months in an oncological outpatient clinic. Immunotherapy activates the body's immune system and thus enables a more active fight against cancer cells.

progress in personalized medicine

Progress in personalized medicine underline the importance of individualized treatment approaches. According to Darmkrebs.de , new therapies aim to activate the immune system specifically against tumor cells. The first successes in immunotherapy in black skin cancer have shown that such treatments can extend the survival of patients.

Research deals intensively with immune checkpoint inhibitors that are also used for colon cancer. These specific active ingredients activate immune cells defense reactions, but must be dosed carefully because they can also attack healthy tissue. In order to increase the effectiveness, researchers plan to develop vaccinations that systematically confront the immune system with tumor -specific antigen. A molecular profile of the tumor helps to select suitable antigens and induce specific immunological reactions.

clinical studies and challenges

The results of the Fire 3 study illustrate the progress in research on personalized cancer therapy. This study compares various treatment approaches in metastatic colon cancer and shows that patients with certain genetic mutations benefit from specific forms of therapy. However, the need for independent clinical studies remains to understand the security and effectiveness of new therapies, such as Krebs-nachrichten.de Notes

In Austria, around 2,000 people die from colon cancer annually. That is why early detection investigations from the age of 45 are strongly recommended, especially in the event of a family preload. The intestinal mirroring represents the central method for diagnosis and prevention. In the Clinic Landstrasse, an endoscopy simulator is even used to teach prospective doctors the implementation of colonoscopy.

Patients who are interested in immunotherapeutic approaches should contact their doctors at an early stage. In addition, the possibility is available to get a first date on the platform oncare.wien within 10 working days, and the Vienna Health Advice on 1450 offers support.